Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

annamycin liposomal

Known as: liposomal annamycin 
A liposome-encapsulated form of the semi-synthetic doxorubicin analogue annamycin with antineoplastic activity. Annamycin intercalates into DNA and… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
BACKGROUND Treatment options for relapsed/refractory ALL in adult patients remain challenging. Annamycin is a highly lipophilic… Expand
Is this relevant?
2012
2012
Acute lymphocytic leukaemia (ALL) is a heterogeneous group of disorders that result from the clonal proliferation and expansion… Expand
  • figure 1
  • figure 2
  • table I
  • figure 3
Is this relevant?
2009
2009
7066 Background: There continues to be no effective second-line therapy for refractory AML or ALL and the cure rate with current… Expand
Is this relevant?
Review
2007
Review
2007
Acute lymphocytic leukaemia (ALL) is a heterogeneous group of disorders that result from the clonal proliferation and expansion… Expand
Is this relevant?
2002
2002
Abstract. Liposomal annamycin (L-AN) has shown antitumor activity in preclinical studies. It may selectively target tumors and… Expand
  • table 1
Is this relevant?
2000
2000
Abstract Annamycin is a highly lipophilic anthracycline with the ability to bypass the MDR-1 mechanism of cellular drug… Expand
Is this relevant?
1997
1997
Recent studies have shown that changes in lipoprotein cholesterol and triglyceride concentration alters the plasma distribution… Expand
Is this relevant?
1997
1997
The objectives of this study were to determine the lipoprotein distribution of unbound annamycin and liposomal annamycin within… Expand
Is this relevant?
1996
1996
Abstract We report a method of preparing a submicron and stable liposome formulation of the non-cross-resistant anthracycline… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
Is this relevant?
1995
1995
Annamycin (Ann) is a lipophilic and non-cross-resistant anthracycline antibiotic currently in clinical development as a liposomal… Expand
Is this relevant?